Article Information
History
- October 14, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Nicholas Khoo Kim Huat1,*,
- Joey Ming Er Lim1,*,
- Upkar S. Gill2,*,
- Ruklanthi de Alwis1,3,
- Nicole Tan1,
- Justin Zhen Nan Toh1,3,
- Jane E. Abbott2,
- Carla Usai2,
- Eng Eong Ooi1,3,
- Jenny Guek Hong Low1,4,
- Nina Le Bert1,#,
- Patrick T. F. Kennedy2,# and
- Antonio Bertoletti1,5,#,†
- 1Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
- 2Barts Liver Centre, Barts and The London School of Medicine & Dentistry, Queen Mary University of London, London, UK
- 3Viral Research and Experimental Medicine Centre (ViREMiCS), SingHealth Duke-NUS Academic Medical Centre, Singapore
- 4Department of Infectious Diseases, Singapore General Hospital, Singapore
- 5Singapore Immunology Network, A*STAR, Singapore
- ↵†Corresponding Author:
Antonio Bertoletti, MD, Programme in Emerging Infectious Diseases, Duke-NUS Medical School, 8 College Road, Singapore 169857, Singapore, Tel: +65 9229 5044, Email: antonio{at}duke-nus.edu.sg
↵* These authors contributed equally
Posted October 14, 2021.
Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients
